Press Releases | Mylan MediaRoom Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low- and Middle-Income Countries Mon, 24 Sep 2018 07:00:00 -0400 Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim Fri, 21 Sep 2018 09:30:00 -0400 Mylan Launches Authorized Generic of Ampyra® Tablets - Mylan's Dalfampridine Extended-Release Tablets, 10 mg, are indicated for patients with multiple sclerosis - Fri, 21 Sep 2018 08:57:00 -0400 Mylan and Fujifilm Kyowa Kirin Biologics Receive European Marketing Authorization for Hulio®, Biosimilar Adalimumab Thu, 20 Sep 2018 07:00:00 -0400 Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI™ (revefenacin) in Oral Presentation at the European Respiratory Society International Congress Reduction in Rates of COPD Exacerbations Observed in COPD Patients Treated with YUPELRI™ Compared to Placebo and Tiotropium (Spiriva ® HandiHaler ® ) Mon, 17 Sep 2018 08:30:00 -0400